Moxisylyte
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 4-[2-(Dimethylamino)ethoxy]-5-isopropyl-2-methylphenyl acetate | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 54-32-0  |
| ATC code | G04BE06 C04AX10 |
| PubChem | CID 4260 |
| UNII | PW8QYA7KI0 |
| KEGG | D08239 |
| Chemical data | |
| Formula | C16H25NO3 |
| Mol. mass | 279.375 g/mol |
 (what is this?) (verify) |
Moxisylyte, also known as thymoxamine, is a drug used in urology used for the treatment of erectile dysfunction. It is an α1-adrenergic antagonist.[1]
[edit] References
- ^ Sakakibara R, Hattori T, Uchiyama T, et al. (March 2000). "Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte". J. Auton. Nerv. Syst. 79 (2–3): 191–5. doi:10.1016/S0165-1838(99)00105-8. PMID 10699651. http://linkinghub.elsevier.com/retrieve/pii/S0165183899001058.
|
|
 |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
 |
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
